相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypoxia suppresses myofibroblast differentiation by changing RhoA activity
Lisa Leinhos et al.
JOURNAL OF CELL SCIENCE (2019)
Effects of different hypoxia degrees on endothelial cell cultures-Time course study
Ioana Baldea et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2018)
The AMP-Related Kinase (AMPK) Induces Ca2+-Independent Dilation of Resistance Arteries by Interfering With Actin Filament Formation
Kai Michael Schubert et al.
CIRCULATION RESEARCH (2017)
The impact of hypoxia and its modification of the outcome of radiotherapy
Michael R. Horsman et al.
JOURNAL OF RADIATION RESEARCH (2016)
Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
Wenjie Liang et al.
ONCOTARGET (2016)
Dual observation of the ATP-evoked small GTPase activation and Ca2+ transient in astrocytes using a dark red fluorescent protein
Yoshihisa Nakahata et al.
SCIENTIFIC REPORTS (2016)
AMPK activators: mechanisms of action and physiological activities
Joungmok Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain
Thomas E. Jensen et al.
BIOCHEMICAL JOURNAL (2015)
Endothelial Cell Metabolism in Normal and Diseased Vasculature
Guy Eelen et al.
CIRCULATION RESEARCH (2015)
An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate
L. J. Williams et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Microtubules and their role in cellular stress in cancer
Amelia L. Parker et al.
FRONTIERS IN ONCOLOGY (2014)
Hypoxia and the modulation of the actin cytoskeleton - emerging interrelations
Anke Zieseniss
HYPOXIA (2014)
Inhibition of AMP-Activated Protein Kinase Accentuates Lipopolysaccharide-Induced Lung Endothelial Barrier Dysfunction and Lung Injury in Vivo
Junjie Xing et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase
Muhammad Aslam et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Novel Small-Molecule AMP-Activated Protein Kinase Allosteric Activator with Beneficial Effects in db/db Mice
Li-Na Zhang et al.
PLOS ONE (2013)
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor
Theodora Fifis et al.
CANCER MEDICINE (2013)
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
Paul D. Ray et al.
CELLULAR SIGNALLING (2012)
Role of RhoB in the Regulation of Pulmonary Endothelial and Smooth Muscle Cell Responses to Hypoxia
Beata Wojciak-Stothard et al.
CIRCULATION RESEARCH (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Acute versus chronic hypoxia in tumors. Controversial data concerning time frames and biological consequences
C. Bayer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates
Thomas Nielsen et al.
ACTA ONCOLOGICA (2010)
Hypoxia Stabilizes Microtubule Networks and Decreases Tumor Cell Chemosensitivity to Anticancer Drugs Through Egr-1
Wan-Xin Peng et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
AMP-activated protein kinase induces actin cytoskeleton reorganization in epithelial cells
Lisa Miranda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
Akiyoshi Hirayama et al.
CANCER RESEARCH (2009)
Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses
Gillian M. Tozer et al.
CLINICAL CANCER RESEARCH (2009)
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Mark W. Dewhirst
RADIATION RESEARCH (2009)
Pulmonary microvascular endothelial cells form a tighter monolayer when grown in chronic hypoxia
Victor Solodushko et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Tumour vascular disrupting agents: combating treatment resistance
G. M. Tozer et al.
BRITISH JOURNAL OF RADIOLOGY (2008)
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors
Gillian M. Tozer et al.
CANCER RESEARCH (2008)
A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism
Daniel Moreno et al.
FEBS LETTERS (2008)
Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells
Tao Pang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo
Constantino Carlos Reyes-Aldasoro et al.
MICROCIRCULATION (2008)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
Radiation effects on the cytoskeleton of endothelial cells and endothelial monolayer permeability
Dorota Gabrys et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
A new synthesis of combretastatins A-4 and AVE-8062A
Francisco Lara-Ochoa et al.
TETRAHEDRON LETTERS (2007)
Characterizing the tumor response to treatment with combretastatin A4 phosphate
Beth A. Salmon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
AMP-activated protein kinase impairs endothelial actin cytoskeleton assembly by phosphorylating vasodilator-stimulated phosphoprotein
Constanze Blume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mitochondria as signaling organelles in the vascular endothelium
M Quintero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells
B Wojciak-Stothard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury
WK Bao et al.
CARDIOVASCULAR RESEARCH (2004)
Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results
GJS Rustin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Rho GTPases show differential sensitivity to nucleotide triphosphate depletion in a model of ischemic cell injury
MA Hallett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2
US Kayyali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells
C Kanthou et al.
BLOOD (2002)
分享论文
